Skip to content

Clinical trials

Recruiting Phase 1/2 Small Cell Lung Carcinoma trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Small Cell Lung Carcinoma Phase: Phase 1/2 Status: Recruiting Clear all

41 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20171
20181
20191
20201
20221
20235
20245
202511
202614

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Recruiting41

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Suzhou Zelgen Biopharmaceuticals Co.,Ltd3
Anhui Provincial Hospital2
Astellas Pharma Global Development, Inc.2
Beijing Biotech2
MediLink Therapeutics (Suzhou) Co., Ltd.2
Novartis Pharmaceuticals2
Arvinas Inc.1
Avenzo Therapeutics, Inc.1
BioNTech SE1
Boehringer Ingelheim1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Small Cell Lung Carcinoma41
Carcinoma, Non-Small-Cell Lung13
Carcinoma, Neuroendocrine6
Colorectal Neoplasms6
Lung Neoplasms6
Squamous Cell Carcinoma of Head and Neck6
Melanoma5
Uterine Cervical Neoplasms5
Carcinoma, Hepatocellular4
Endometrial Neoplasms4

Trials

Showing 1 to 25 of 41. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.